<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03073460</url>
  </required_header>
  <id_info>
    <org_study_id>16-037</org_study_id>
    <nct_id>NCT03073460</nct_id>
  </id_info>
  <brief_title>The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Labour at Term</brief_title>
  <official_title>The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Labour at Term</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unity Health Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unity Health Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The exact mechanism stimulating the parturition in humans is still relatively unknown.&#xD;
      Prostaglandins, by mediating cervical ripening and early stimulation of myometrial&#xD;
      contractions, are likely to play a major role in the parturition process. Much of the unique&#xD;
      fetal circulation is facilitated by the ductus arteriosus. Patency of the ductus arteriosus&#xD;
      in utero is primarily maintained via prostaglandins which are highly expressed by smooth&#xD;
      muscle cells located in the media of the ductus arteriosus. The aim of the study is to&#xD;
      prospectively observe fetal ultrasound changes related to the ductus arteriosus. The primary&#xD;
      objective is to prospectively assess, whether any changes in the fetal ductus arteriosus&#xD;
      parameters exist at 40 weeks' gestation. The secondary objective is to investigate whether&#xD;
      there is an association between the ductus arteriosus parameters and the time to delivery&#xD;
      interval at 40 weeks' gestation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The rationale is to assess whether physiological responses that occur around the time of&#xD;
      delivery, in both the mother and the fetus (elevated prostaglandins level), can be quantified&#xD;
      using ultrasound of the fetal ductus arteriosus.&#xD;
&#xD;
      Whether or not the DA plays an active physiological role in the initiation of parturition is&#xD;
      still unknown. Since prostaglandins are physiologically highly expressed within the fetal&#xD;
      ductus arteriosus and also linked to some critical steps throughout parturition, it is&#xD;
      hypothesized that structural and doppler flow pattern variations of the ductus arteriosus&#xD;
      exist in the period surrounding the birth. These changes might occur before or after the&#xD;
      intrinsic rise of prostaglandins and could be quantified using prenatal ultrasound of the&#xD;
      fetal DA.&#xD;
&#xD;
      Identifying new physiological based variables that can assist in predicting the onset of&#xD;
      labour, as the one suggested in the current study, is thus of great importance and may&#xD;
      provide invaluable information into the overall future care and decision making during&#xD;
      pregnancy, especially around the time of delivery. It may assist in creating future&#xD;
      recommendations for pregnant women and improved healthcare standards during the delivery&#xD;
      process.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Not able to recruit any participants&#xD;
  </why_stopped>
  <start_date type="Anticipated">June 2, 2016</start_date>
  <completion_date type="Actual">March 28, 2020</completion_date>
  <primary_completion_date type="Actual">March 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fetal ductus arteriosus changes</measure>
    <time_frame>40 weeks gestation</time_frame>
    <description>To prospectively assess whether any changes in blood flow in the fetal ductus arteriosus exist at 40 weeks' gestation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to delivery</measure>
    <time_frame>From 40 weeks gestation to delivery</time_frame>
    <description>To investigate whether there is an association between the ductus arteriosus blood flow and the time to delivery interval at 40 weeks' gestation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Ductus Arteriosus</condition>
  <arm_group>
    <arm_group_label>Ultrasound examination</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will undergo an ultrasound examination at 40 weeks gestation to assess the fetal ductus arteriosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound examination</intervention_name>
    <description>This exam is performed at 40 weeks gestation</description>
    <arm_group_label>Ultrasound examination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Low risk singleton pregnancy at 40 weeks gestation.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Underlying cardiac or respiratory illness&#xD;
&#xD;
          -  Fetal growth restriction&#xD;
&#xD;
          -  Medicated gestational hypertension or evolving preeclampsia&#xD;
&#xD;
          -  Gestational diabetes controlled with insulin or oral medications&#xD;
&#xD;
          -  Use of steroids for lung maturation in the current pregnancy&#xD;
&#xD;
          -  Known major congenital anomalies.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women with a singleton pregnancy</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Berger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unity Health Toronto</affiliation>
  </overall_official>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>April 28, 2020</last_update_submitted>
  <last_update_submitted_qc>April 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ductus Arteriosus, Patent</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

